{"title": "News and resources - IFPMA", "author": null, "url": "https://www.ifpma.org/news-and-resources/", "hostname": "ifpma.org", "description": null, "sitename": "IFPMA", "date": "2022-10-04", "cleaned_text": "Our perspectives in one place [Filters] Topic ](https://www.ifpma.org/insights/the-importance-of-a-thriving-innovation-ecosystem-a-look-at-how-hepatitis-c-was-identified-and-cured/) The importance of a thriving innovation ecosystem: A look at how Hepatitis C was identified and cured Innovation often comes in waves, set in motion by science. Such was the case when a cure was found for hepatitis C virus (HCV). It was followed by others in quick succession, giving us multiple tools to successfully tackle the disease. The story of HCV shows us what a thriving innovation ecosystem can achieve -...Read more [ ](https://www.ifpma.org/publications/action-on-ncds/) Action on NCDs: How the innovative pharmaceutical industry helps bridge the care gap In the spirit of the Global Week for Action on NCDs, this report reiterates the long-standing commitment of the innovative pharmaceutical industry to bring innovative solutions, bridge the NCDs care gap, and accelerate Universal Health Coverage (UHC) and the 2030 Sustainable Development Goals (SDGs).Read more [ ](https://www.ifpma.org/news/statement-at-the-73rd-regional-committee-for-africa/) Statement at the 73rd Regional Committee for Africa On 30 August, IFPMA submitted a statement at the 73rd Regional Committee for Africa in Gaborone, Botswana on the Framework for sustaining resilient health systems to achieve universal coverage and promote health security, 2023-2030 in the WHO African Region.Read more [Action on NCDs: How the innovative pharmaceutical industry helps bridge the care gap] [The importance of a thriving innovation ecosystem: A look at how Hepatitis C was identified and cured] [Action on NCDs: How the innovative pharmaceutical industry helps bridge the care gap] [Statement at the 73rd Regional Committee for Africa] News [See all](https://www.ifpma.org/news-and-resources/#news) [](https://www.ifpma.org/news/statement-at-the-73rd-regional-committee-for-africa/) Statement at the 73rd Regional Committee for Africa On 30 August, IFPMA submitted a statement at the 73rd Regional Committee for Africa in Gaborone, Botswana on the Framework for sustaining resilient health systems to achieve universal coverage and promote health security, 2023-2030 in the WHO African Region.Read more [](https://www.ifpma.org/news/fourth-meeting-of-the-working-group-on-amendments-to-the-international-health-regulations/) Fourth meeting of the Working Group on Amendments to the International Health Regulations On 24 July, IFPMA made a statement at the fourth meeting of the Working Group on Amendments to the International Health Regulations (2005) in Geneva.Read more [](https://www.ifpma.org/news/joint-plenary-meeting-of-the-intergovernmental-negotiating-body-inb-and-the-working-group-on-amendments-to-the-international-health-regulations-agenda-item-3/) Joint Plenary Meeting of the Intergovernmental Negotiating Body (INB) and the Working Group on Amendments to the International Health Regulations: Agenda item 3 On 24 July, IFPMA delivered a statement for agenda item 3 at the \"Joint Plenary Meeting of the Intergovernmental Negotiating Body (INB) to draft and negotiate a WHO convention, agreement, or other international instrument on pandemic prevention, preparedness, and response and the Working Group on Amendments to the International Health Regulations (WGIHR) (2005)\" in Geneva.Read more [](https://www.ifpma.org/news/joint-plenary-meeting-of-the-intergovernmental-negotiating-body-inb-and-the-working-group-on-amendments-to-the-international-health-regulations-wgihr-2005/) Joint Plenary Meeting of the Intergovernmental Negotiating Body (INB) and the Working Group on Amendments to the International Health Regulations: Agenda item 2 On 21 July, IFPMA delivered a statement for agenda item 2 at the \"Joint Plenary Meeting of the Intergovernmental Negotiating Body (INB) to draft and negotiate a WHO convention, agreement, or other international instrument on pandemic prevention, preparedness, and response and the Working Group on Amendments to the International Health Regulations (WGIHR) (2005)\" in Geneva.Read more [](https://www.ifpma.org/news/global-regulators-and-biopharmaceutical-and-vaccine-industry-to-share-experiences-with-managing-pharmaceutical-quality-systems/) Global regulators and biopharmaceutical and vaccine industry to share experiences with managing pharmaceutical quality systems On 20 July 2023, the International Coalition of Medicines Regulatory Authorities (ICMRA) is hosting a virtual workshop on the development of a global Pharmaceutical Quality Knowledge Management System (PQ KMS), which aims to facilitate the exchange of knowledge related to pharmaceutical quality amongst national regulatory authorities worldwide.Read more [](https://www.ifpma.org/news/global-biopharmaceutical-trade-body-announces-new-ceo-leadership-team/) Global biopharmaceutical trade body announces new CEO leadership team CEOs from Pfizer, Roche, and Daiichi Sankyo take up roles on IFPMA CEO leadership team The global biopharmaceutical industry trade body, the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA), has announced a new line up for their CEO leadership team for the coming two years. The CEOs who will provide strategic guidance to the...Read more Publications [See all](https://www.ifpma.org/news-and-resources/#publications) [ ](https://www.ifpma.org/publications/action-on-ncds/) Action on NCDs: How the innovative pharmaceutical industry helps bridge the care gap In the spirit of the Global Week for Action on NCDs, this report reiterates the long-standing commitment of the innovative pharmaceutical industry to bring innovative solutions, bridge the NCDs care gap, and accelerate Universal Health Coverage (UHC) and the 2030 Sustainable Development Goals (SDGs).Read more [ ](https://www.ifpma.org/publications/ifpma-note-for-guidance-on-sponsorship-of-events-and-meetings-2023-update-2/) IFPMA Note for Guidance on sponsorship of events and meetings (2023 update) Collaborations between healthcare professionals (HCPs) and the pharmaceutical industry are essential and ensure that patients have access to the medicines they need and that healthcare professionals have up-to-date comprehensive information about the diseases they treat and the medicines they prescribe.Read more [ ](https://www.ifpma.org/publications/reinforcing-collaboration-on-universal-health-coverage-to-deliver-greater-global-health-equity-and-health-security/) Reinforcing collaboration on Universal Health Coverage to deliver greater global health equity and health security The innovative pharmaceutical industry stands together with other members of the global health community to support countries in accelerating their efforts to achieve UHC. Read our position paper.Read more Expert insights [See all](https://www.ifpma.org/news-and-resources/#insights) [](https://www.ifpma.org/insights/the-importance-of-a-thriving-innovation-ecosystem-a-look-at-how-hepatitis-c-was-identified-and-cured/) The importance of a thriving innovation ecosystem: A look at how Hepatitis C was identified and curedRead more [](https://www.ifpma.org/insights/ushering-in-a-new-era-for-cancer-therapy/) Ushering in a new era for cancer therapyRead more [](https://www.ifpma.org/insights/uplifting-youth-as-ambassadors-of-innovation-in-the-pharma-industry/) Uplifting youth as ambassadors of innovation in the pharma industryRead more Resources [See all](https://www.ifpma.org/news-and-resources/#resources) [ ](https://www.ifpma.org/resources/action-on-ncds/) Action on NCDs: How the innovative pharmaceutical industry helps bridge the care gapRead more [ ](https://www.ifpma.org/resources/navigating-the-ecowas-joint-assessment-procedure/) Navigating the ECOWAS Joint Assessment Procedure The ECOWAS Joint Assessment Procedure is a collaborative initiative among 15 National Regulatory Agencies in West Africa that ensures harmonized and streamlined market authorization of medical products across the region. This infographic provides an overview of key steps and timelines applicants need to bear in mind during the Joint Assessment Procedure.Read more [ ](https://www.ifpma.org/resources/advancing-universal-health-coverage-in-africa/) Advancing universal health coverage in Africa Universal Health Coverage (UHC) is at the heart of the health-related Sustainable Development Goals (SDGs). It is the foundation for both global health security and the health and well-being of all people throughout their lifetimes. Africa's health systems are essential in delivering the UHC2030 action agenda. Given Africa's population is expected to double by 2050,...Read more "}